Rekombinanter NAPSA Antikörper (AA 50-150)
Kurzübersicht für Rekombinanter NAPSA Antikörper (AA 50-150) (ABIN7875322)
Target
Alle NAPSA Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 50-150
-
Verwendungszweck
- Recombinant Napsin A Antibody
-
Aufreinigung
- Protein A affinity chromatography
-
Immunogen
- A portion of amino acids 50-150 from the human protein was used as the immunogen for the recombinant Napsin A antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the recombinant Napsin A antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the recombinant Napsin A antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- NAPSA (Napsin A Aspartic Peptidase (NAPSA))
-
Andere Bezeichnung
- Napsin A
-
Hintergrund
- Napsin is a pepsin-like aspartic proteinase connected with maturation of surfactant protein B.There are two closely related napsins, napsin A and napsin B. Napsin A is expressed as a single chain protein. Immunohistochemical studies revealed high expression levels of napsin A in human lung and kidney but low expression in spleen. Napsin A is expressed in type II pneumocytes and in adenocarcinomas of lung. The high specificity expression of napsin A in adenocarcinomas of lung is useful to distinguish primary lung adenocarcinomas from adenocarcinomas of other organs.
-
UniProt
- O96009
-
Pathways
- Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis
Target
-